Crohn’s Disease Treatment Market to surpass US$ 15.17 Bn by 2030

 

Crohns Disease Treatment Market

Crohn's disease is a type of inflammatory bowel disease (IBD) that is characterised by a chronic inflammatory condition of the gastrointestinal tract that results in digestive tract inflammation. The disease is limited to the large intestine's colon and the small intestine's ileum. The disease is frequently painful and debilitating, and in some cases can result in life-threatening complications. Complications may include one or more of the following: bowel obstruction, fistulas, ulcers, anal fissures, colon cancer, and other health issues. Factors such as stress, diet, heredity, and immune system malfunction can all contribute to Crohn's disease. The disease can strike anyone at any age. However, the majority of people will develop it at a young age.

The rising prevalence of inflammatory bowel diseases is expected to propel the crohn's disease treatment market forward. Factors such as an increase in the number of inflammatory bowel diseases (IBD) and an increase in the number of Crohn's disease patients are expected to significantly contribute to the growth of the Crohn's disease treatment market. For example, in May 2021, an illness-death model based on available data was established to project the future prevalence of IBD in Asia, and Iran in particular, from 2017 to 2035, according to an article published in the Journal BMC Gastroenterology.

Global Crohns Disease Treatment Market is estimated to be valued at US$ 10.92 billion in 2022 and is expected to exhibit a CAGR of 4.2% during the forecast period (2022-2030)

According to the findings, the study predicted a 2.5-fold increase in prevalence for Iran with 69 thousand cases, a 2.3-fold increase for North Africa and the Middle East with 220 thousand cases, a quadrupling of the prevalence for India with 2.2 million cases, a 1.5-fold increase for East Asia with 4.5 million cases, and a 1.6-fold increase for high-income Asia Pacific and Southeast Asia regions with 183 and 199 thousand cases, respectively, in 2035.

The development of new and effective therapy options to treat Crohn's disease symptoms is also an important factor contributing to the growth of the Crohn's disease treatment market. For example, at the Crohn's & Colitis Congress in January 2018, researchers from the University of Washington Medicine presented a study that developed an antibiotic that showed a fourfold better response on intestine inflammation among Crohn's disease patients when compared to existing therapies on the market.

Because of the disease exacerbation caused by the COVID-19 pandemic, the COVID-19 pandemic had a significant impact on the crohn's disease treatment market. For example, according to an article published in December 2021 by Frontiers Media S.A., a questionnaire survey on patients with Inflammatory Bowel Disease (IBD) was conducted from June 16 to August 21, 2020, during their regular follow-up at a hospital in Japan. According to the findings, 241 patients with ulcerative colitis (UC) and 210 patients with Crohn's disease (CD) completed the survey, with 82 (34%) and 97 (46%) reporting disease exacerbation within 2 months of the lockdown, respectively.

Comments

Popular posts from this blog

Electric Wheelchair Market Size, Share, Outlook, and Opportunity Analysis, 2021 – 2028

Crude Tall Oil Market is Anticipated to Witness High Growth Owing to Rising Demand from Construction Industry

The Global Benzocaine Market Size Is Expected To Exhibit A Cagr Of 2.70% Over The Forecast Period (2020-2027).